Jill Barber

ORCID: 0000-0002-5424-0291
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms
  • Mass Spectrometry Techniques and Applications
  • Cancer therapeutics and mechanisms
  • Metabolomics and Mass Spectrometry Studies
  • RNA and protein synthesis mechanisms
  • Advanced Proteomics Techniques and Applications
  • Chemical Synthesis and Analysis
  • Analytical Chemistry and Chromatography
  • Carbohydrate Chemistry and Synthesis
  • DNA and Nucleic Acid Chemistry
  • Toxoplasma gondii Research Studies
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Resistance in Bacteria
  • Pneumonia and Respiratory Infections
  • Microbial Natural Products and Biosynthesis
  • Amino Acid Enzymes and Metabolism
  • Parasitic Infections and Diagnostics
  • Herpesvirus Infections and Treatments
  • Chemical Reactions and Isotopes
  • Molecular spectroscopy and chirality
  • Computational Drug Discovery Methods
  • Pharmacological Effects and Toxicity Studies
  • Bacterial Genetics and Biotechnology
  • Enzyme Structure and Function

University of Manchester
2016-2025

Manchester Academic Health Science Centre
2022-2025

University of Rhode Island
2022

Simcyp (United Kingdom)
2014-2022

Merck (Germany)
2021

Certara (United States)
2014-2021

Tanta University
2020-2021

Wellcome Centre for Cell-Matrix Research
2020

Manchester University
2020

Salford Royal NHS Foundation Trust
2020

Cytochrome P450 (P450) and uridine 5′-diphospho-glucuronosyltransferase (UGT) enzymes mediate a major proportion of phase I II metabolism xenobiotics. In vitro-in vivo extrapolation (IVIVE) hepatic clearance in conjunction with physiologically-based pharmacokinetics (PBPK) has become common practice drug development. However, prediction xenobiotic kinetics virtual populations requires knowledge both enzyme abundances the extent to which these correlate. A multiplexed quantification...

10.1124/dmd.113.055632 article EN Drug Metabolism and Disposition 2014-01-09

The blood-brain barrier (BBB) maintains brain homeostasis by controlling traffic of molecules from the circulation into brain. This function is predominantly dependent on proteins expressed at BBB, especially transporters and tight junction proteins. Alterations to level BBB can impact susceptibility central nervous system exposure xenobiotics in systemic with potential consequent effects function. In this study, expression profiles drug solute carriers were assessed tissues healthy...

10.1021/acs.molpharmaceut.8b01189 article EN Molecular Pharmaceutics 2019-02-08

Glutathione reductase (Glr1) is a low abundance protein involved in defense mechanisms against reactive oxygen species. Expressed on cytosolic ribosomes, the same gene, GLR1, uses alternative start codons to generate two forms of Glr1. Translation from first AUG codon generates mitochondrial form incorporating presequence necessary for import; translation second yields counterpart. Proteomic strategies were used analyze N-terminal sequences and turnover Saccharomyces cerevisiae The...

10.1021/pr4001948 article EN Journal of Proteome Research 2013-04-30

Quantitative translation of information on drug absorption, disposition, receptor engagement, and drug–drug interactions from bench to bedside requires models informed by physiological parameters that link in vitro studies vivo outcomes. To predict outcomes, biochemical data experimental systems are routinely scaled using protein quantity these relevant tissues. Although several laboratories have generated useful quantitative proteomic state‐of‐the‐art mass spectrometry, no harmonized...

10.1002/cpt.1537 article EN Clinical Pharmacology & Therapeutics 2019-06-08

The levels of drug-metabolizing enzymes (DMEs) and transporter proteins in the human intestine are pertinent to determine oral drug bioavailability. Despite paucity reports on such measurements, it is well recognized that these values essential for translating vitro data metabolism transport predict disposition gut wall. In current study, clinically relevant DMEs [cytochrome P450 (P450) uridine 5′-diphospho-glucuronosyltransferase (UGT)] transporters were quantified total mucosal protein...

10.1124/dmd.119.089656 article EN cc-by-nc Drug Metabolism and Disposition 2020-01-20

Twenty‐seven cases of neosporosis in European dogs are described. The disease was confirmed by immunohistochemistry, electron microscopy, or a favourable response to treatment the with appropriate clinical signs, and presence antibodies Neospora caninum but not Toxoplasma gondii . affected were two days seven years old, 13 different breeds. Both sexes most littermates remained normal. Twenty‐one had an initial hindlimb paresis ataxia, which muscle atrophy consistent sign. Rigid...

10.1136/vr.139.18.439 article EN Veterinary Record 1996-11-01

A total of 1,554 dogs from 5 countries on 3 continents were tested for antibodies to Neospora caninum using an indirect fluorescent antibody test. In Australia, overall, 42/451 (9%, 95% confidence interval [CI] 6-12%) seropositive (Melbourne 11/207 [5%, CI 2-9%]; Sydney 18/150 [12%, 7-18%]; Perth 13/94 [14%, 8-22%]). Antibodies N. also detected in South America (Uruguay [20%, 16-24%, n = 414]) and sub-Saharan Africa (Tanzania [22%, 12-36%, 49]). contrast, only 1 500 the Falkland Islands none...

10.2307/3284361 article EN Journal of Parasitology 1997-12-01

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMinor-groove recognition of the self-complementary duplex d(CGCGAATTCGCG)2 by Hoechst 33258: a high-field NMR studyJohn A. Parkinson, Jill Barber, Kenneth T. Douglas, John Rosamond, and Derek SharplesCite this: Biochemistry 1990, 29, 44, 10181–10190Publication Date (Print):November 1, 1990Publication History Published online1 May 2002Published inissue 1 November...

10.1021/bi00496a005 article EN Biochemistry 1990-11-01

The cytochrome P450 (P450) family of enzymes is a major player in the metabolism therapeutic drugs available on market, and development novel has to take into account these fate new drugs. Testing pharmacokinetic behavior animals common part drug process. Pigs are increasingly used for this purpose because their similarity enzymatic pattern humans. In study, adult Suffolk White pig liver microsomal samples were analyzed using mass-spectrometry-based techniques identify relatively quantify...

10.1124/dmd.111.040618 article EN Drug Metabolism and Disposition 2011-07-27

In the present work, two different proteomic platforms, gel-based and gel-free, were used to map matrix outer membrane vesicle exoproteomes of Pseudomonas aeruginosa PAO1 biofilms. These strategies allowed us a confident identification 207 327 proteins from enriched vesicles whole isolated Because physicochemical characteristics these subproteomes, showed complementarity, thus, most comprehensive analysis P. exoproteome date was achieved. Under our conditions, contribute approximately 20%...

10.1021/acs.jproteome.5b00312 article EN Journal of Proteome Research 2015-08-25

There is an urgent need (recognized in FDA guidance, 2018) to optimize the dose of medicines given patients for maximal drug efficacy and limited toxicity (precision dosing), which can be facilitated by quantitative systems pharmacology (QSP) models. Accurate quantification proteins involved clearance essential build improve QSP models any target population. Here we describe application label-free proteomics microsomes from 23 human livers simultaneously quantify 188 enzymes 66 transporters...

10.1021/acs.molpharmaceut.8b00941 article EN Molecular Pharmaceutics 2019-01-04

Variability in individual capacity for hepatic elimination of therapeutic drugs is well recognized and associated with variable expression activity liver enzymes transporters. Although genotyping offers some degree stratification, there often large variability within the same genotype. Direct measurement protein impractical due to limited access tissue biopsies. Hence, determination drug metabolism disposition using liquid biopsy (blood samples) an attractive proposition during development...

10.1002/cpt.2102 article EN cc-by-nc Clinical Pharmacology & Therapeutics 2020-11-03

Abstract The blood–brain barrier ( BBB ) maintains brain homeostasis by tightly regulating the exchange of molecules with systemic circulation. It consists primarily microvascular endothelial cells surrounded astrocytic endfeet, pericytes, and microglia. Understanding make‐up transporters in rat is essential to translation pharmacological toxicological observations into humans. In this study, experimental workflows are presented which optimization (a) isolation microvessels (b) enrichment...

10.1111/jnc.14446 article EN Journal of Neurochemistry 2018-04-20

Liver cirrhosis is a chronic disease that affects the liver structure, protein expression, and overall metabolic function. Abundance data for drug-metabolizing enzymes transporters (DMET) across all stages of severity are scarce. Levels these proteins crucial accurate prediction drug clearance in hepatically impaired patients using physiologically based pharmacokinetic (PBPK) models, which can be used to guide selection more precise dosing. This study aimed experimentally quantify human...

10.1021/acs.molpharmaceut.1c00462 article EN cc-by Molecular Pharmaceutics 2021-08-24

10.1016/s0020-7519(97)00171-9 article EN International Journal for Parasitology 1998-01-01

SUMMARY An indirect enzyme linked immunosorbent assay (ELISA) for detection of antibodies to Neospora caninum in serum from dogs is described. Extracted tachyzoite proteins incorporated into immunostimulating complexes (iscoms) were used as coating antigen. A mixture a monoclonal antibody dog immunoglobulin G and horse radish peroxidase conjugated mouse Ig was detect bound antibody. When the iscom preparation analysed by means sodium dodecyl sulphate polyacrylamide gel electrophoresis it...

10.1111/j.1365-3024.1994.tb00320.x article EN Parasite Immunology 1994-12-01

SUMMARY Neospora caninum is an apicomplexan, protozoan parasite, which causes severe disease in dogs and cattle. It has previously been isolated only the United States. A 5-week-old Boxer pup with a progressive hindlimb paresis was diagnosed as suffering from neosporosis on basis of clinical signs presence anti- antibodies it, 2 litter-mates its darn. Despite treatment sulphonamides, euthanased 3 days later. The diagnosis confirmed by immunohistochemical examination muscle CNS tissue...

10.1017/s0031182000077039 article EN Parasitology 1995-12-01

QconCAT is a tool for quantitative proteomics, consisting of an artificial protein, expressed from gene, made up concatenated string proteotypic peptides selected the proteins under study. Isotopically labeled (usually containing 13C6-arginine and 13C6-lysine) provides standard each peptide included in its sequence. In practice, some fail to express at sufficient levels purpose analysis. Two complementary methods are presented recalcitrant intended quantify human hepatic enzymes transporters.

10.1021/pr400279u article EN Journal of Proteome Research 2013-10-14

Many genetic and environmental factors lead to interindividual variations in the metabolism transport of drugs, profoundly affecting efficacy toxicity. Precision dosing, that is, targeting drug dose a well characterized subpopulation, is dependent on quantitative models profiles drug-metabolizing enzymes (DMEs) transporters within informed by proteomics. We report first use ion mobility–mass spectrometry for this purpose, allowing rapid, robust, label-free quantification human liver...

10.1124/dmd.116.074732 article EN Drug Metabolism and Disposition 2017-04-03

Quantitative characterization of UDP-glucuronosyltransferase (UGT) enzymes is valuable in glucuronidation reaction phenotyping, predicting metabolic clearance and drug-drug interactions using extrapolation exercises based on pharmacokinetic modeling. Different quantitative proteomic workflows have been employed to quantify UGT various systems, with reports indicating large variability expression, which cannot be explained by interindividual alone. To evaluate the effect methodological...

10.1124/dmd.117.076703 article EN Drug Metabolism and Disposition 2017-08-02
Coming Soon ...